KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) EPS (Weighted Average and Diluted): 2017-2024

Historic EPS (Weighted Average and Diluted) for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to -$2.96.

  • BioNTech SE's EPS (Weighted Average and Diluted) rose 78.94% to -$182.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $516.59, marking a year-over-year increase of 112.15%. This contributed to the annual value of -$2.96 for FY2024, which is 171.83% down from last year.
  • BioNTech SE's EPS (Weighted Average and Diluted) amounted to -$2.96 in FY2024, which was down 171.83% from $4.12 recorded in FY2023.
  • In the past 5 years, BioNTech SE's EPS (Weighted Average and Diluted) ranged from a high of $45.34 in FY2021 and a low of -$2.96 during FY2024.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $4.12 (2023), whereas its average is $13.23.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 63,273.26% in 2021, then crashed by 171.83% in 2024.
  • BioNTech SE's EPS (Weighted Average and Diluted) (Yearly) stood at $0.07 in 2020, then skyrocketed by 63,273.26% to $45.34 in 2021, then declined by 15.00% to $38.53 in 2022, then slumped by 89.31% to $4.12 in 2023, then crashed by 171.83% to -$2.96 in 2024.